Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Musculoskeletal News Roundup 24-Feb-17 BY BLAKE MOSSY, FEBRUARY 24, 2017

Wenzel Spine completed its acquisition of OsteoMed's PrimaLOK SP Interspinous Fusion System and PrimaLOK FF Facet Fixation System. The patented PrimaLOK SP and FF platforms include a polyaxial interspinous process device and percutaneous facet screw system which is designed for minimally invasive surgical treatments for lumbar spinal disorders. This transaction expands Wenzel Spine's product portfolio and will supplement the company's efforts to strengthen its development pipeline of minimally invasive surgical products.

Corin Group launched its Humelock Reversed Shoulder System, a device used to treat patients with a massive rotator cuff tear and a severe form of shoulder arthritis, causing pain and reduced mobility in the arm and shoulder. The system received FDA clearance in January 2017 and is currently available in Europe and other international markets. The company holds a distribution agreement for the device in the United States, Germany and the United Kingdom.

GS Medical announced the launch of its AnyPlus Anterior Cervical Interbody Fusion (ACIF) implant and its AnyPlus Dual-Lead Pedicle Screw System. The company is seeking distributor partnership opportunities and is currently focused on spinal products spanning lumbar, thoracic and cervical applications.

Paragon 28 launched its Gorilla Medial Column Plating System for Charcot and midfoot reconstruction. The system offers 36 titanium plating options to address variations in patient anatomy and levels of deformity, and all plates accept both R3CON and TuffNeck screws.

Paragon 28 launched its PRESERVE HammerGraft System, aseptically-processed allograft implants for the treatment of hammertoe deformity. The system includes four allograft implants in 2.3 and 2.8mm straight and angled formats, harvested from the cortical rim of the tibia or femur. Aseptic processing is used to avoid the potential reduction of osteoinductivity and structural fatigue that may occur from bleaching. The system also includes dense cancellous spacers that are designed to fit over the HammerGraft.

VEXIM completed enrollment in its international clinical trial to support FDA 510(k) submission for its SpineJack in the US. The multicenter, prospective and randomized study aims to compare the safety and efficacy of the SpineJack versus balloon kyphoplasty on 152 patients with osteoporotic vertebral compression fractures.

Active Implants appointed Ted David as company president Chief Executive Officer (CEO). Mr. Davis will succeed Henry Kylce, who will continue his role as chairman of the board. Prior to Active Implants, Mr. Davis served as CEO of MicroPort Orthopedics and president of its predecessor, Wright Medical Technology's global OrthoRecon division, from 2012 through 2015.

Xtant Medical appointed Carl O'Connell as its permanent Chief Executive Officer (CEO), effective February 17th, 2017. Mr. O'Connell previously served as president of Xtant since October of 2016 and was appointed as interim CEO on January 21st, 2017. Prior to Xtant, Mr. O'Connell served as Vice President Global Marketing- Extremities for Wright Medical.

Email this to a colleague: